The Situation ____________ A clinical-stage biopharmaceutical company, dedicated to addressing psychiatric and neurological conditions, faced significant challenges in staying informed of rapid developments in Alzheimer’s psychosis and schizophrenia markets. With key business decisions and an impending product launch on the horizon, the client required timely, actionable insights to effectively navigate competitive landscapes and shifting market dynamics. The Solution ____________ Sedulo …
